Literature DB >> 19937367

BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Frauke Kramer1, Timo Stöver, Athanasia Warnecke, Marc Diensthuber, Thomas Lenarz, Kirsten Wissel.   

Abstract

The expression of neurotrophic factors, such as artemin, glial cell line-derived neurotrophic factor (GDNF), neurturin, transforming growth factors (TGF)-beta1/beta2 and brain-derived neurotrophic factor (BDNF), is enhanced in vestibular schwannomas compared to peripheral nerves. Furthermore, this upregulation may correlate with mitotic activity. Vestibular schwannoma arising from Schwann cells of the vestibular nerve are mostly benign and slow-growing. Most of the pathogenic mechanisms regulating the vestibular schwannoma growth process are unknown. An impaired growth regulation and imbalance between mitosis and apoptosis can be assumed. However, molecular mechanisms interfering with regulation of the vestibular schwannoma growth also modulated by mitogenic factors have to be identified. Neurotrophic factors are involved in regulation of developmental processes in neuronal tissues and regeneration after peripheral nerve trauma and also reveal mitogenic effects on glial cell populations. Gene expression profiles of artemin, BDNF, GDNF, TGF-beta1/beta2 and Ret were determined in the vestibular schwannoma in comparison to the peripheral nerve tissues by using semiquantitative RT-PCR. The expression data were correlated to the proliferation-associated Ki-67 labelling index. A significant higher BDNF expression was observed in the vestibular schwannoma, whereas gene expression of artemin and GDNF was upregulated in peripheral nerves. The correlation between LI and BDNF, TGF-beta1 and Ret was found to be significant in the vestibular schwannoma. Our results demonstrate a coherence between BDNF expression and proliferative activity in the vestibular schwannoma. Based on these results, we propose a pivotal role for BDNF in modulating the vestibular schwannoma growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937367     DOI: 10.1007/s11060-009-0063-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  51 in total

1.  The neurotrophin receptor p75NTR as a positive modulator of myelination.

Authors:  Jose M Cosgaya; Jonah R Chan; Eric M Shooter
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

2.  Expression of transforming growth factor-beta receptor type 1 and type 2 in human sporadic vestibular Schwannoma.

Authors:  Mathias Löttrich; Christian Mawrin; Kathrin Chamaon; Elmar Kirches; Knut Dietzmann; Bernd Freigang
Journal:  Pathol Res Pract       Date:  2007-02-20       Impact factor: 3.250

3.  Expression of transforming growth factor-beta isoforms and their receptors in lepromatous and tuberculoid leprosy.

Authors:  C A Kiszewski; E Becerril; J Baquera; L D Aguilar; R Hernández-Pando
Journal:  Scand J Immunol       Date:  2003-03       Impact factor: 3.487

Review 4.  The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.

Authors:  Stephen D Skaper
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-02       Impact factor: 4.388

5.  Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

Authors:  A Wimmel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

6.  Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.

Authors:  Dimitrios Koutsimpelas; Tobias Stripf; Ulf R Heinrich; Wolf J Mann; Juergen Brieger
Journal:  Otol Neurotol       Date:  2007-12       Impact factor: 2.311

7.  Glial cell-line derived neurotrophic factor (GDNF) family of ligands confer chemoresistance in a ligand-specific fashion in malignant gliomas.

Authors:  Wai Hoe Ng; Guo Qiang Wan; Zhong Ni Peng; Heng Phon Too
Journal:  J Clin Neurosci       Date:  2009-01-12       Impact factor: 1.961

8.  RET protein promotes non-adherent growth of NB-39-nu neuroblastoma cell line.

Authors:  Hitoyasu Futami; Ryuichi Sakai
Journal:  Cancer Sci       Date:  2009-02-20       Impact factor: 6.716

9.  BDNF exerts contrasting effects on peripheral myelination of NGF-dependent and BDNF-dependent DRG neurons.

Authors:  Junhua Xiao; Agnes W Wong; Melanie M Willingham; Selma K Kaasinen; Ian A Hendry; Jason Howitt; Ulrich Putz; Graham L Barrett; Trevor J Kilpatrick; Simon S Murray
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  [Growth of sporadic vestibular schwannomas correlates with Ki-67 proliferation index].

Authors:  H Steinhart; F Triebswetter; S Wolf; H Gress; J Bohlender; H Iro
Journal:  Laryngorhinootologie       Date:  2003-05       Impact factor: 1.057

View more
  6 in total

1.  The microenvironment in the Hirschsprung's disease gut supports myenteric plexus growth.

Authors:  Cornelia Irene Hagl; Ulrich Rauch; Markus Klotz; Sabine Heumüller; David Grundmann; Sabrina Ehnert; Ulrike Subotic; Stefan Holland-Cunz; Karl-Herbert Schäfer
Journal:  Int J Colorectal Dis       Date:  2012-06       Impact factor: 2.571

2.  Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors:  Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

3.  Smooth muscle proteins from Hirschsprung's disease facilitates stem cell differentiation.

Authors:  Cornelia Irene Hagl; Sabine Heumüller; Markus Klotz; Ulrike Subotic; Lucas Wessel; Karl-Herbert Schäfer
Journal:  Pediatr Surg Int       Date:  2012-02       Impact factor: 1.827

4.  Age-related schwannomatosis with potential exosome-mediated contribution to prostate hyperplasia: a case report and mini-review.

Authors:  Bérengère Chignon-Sicard; Véronique Hofman; Daniel Chevallier; Jean-Michel Cucchi; Marius Ilié; Bérengère Dadone-Montaudié; Florence Paul; Xavier Carpentier; Hervé Quintens; Coraline Bence-Gauchiez; Didier Caselles; Jacqueline Rossant; Matthieu Durand; Roger Bertolotti
Journal:  Ther Adv Urol       Date:  2019-09-26

5.  BAY 61-3606, CDKi, and sodium butyrate treatments alter gene expression in human vestibular schwannomas and cause cell death in vitro.

Authors:  Rohan Mitra; Indira Devi Bhagavatula; Rajalakshmi Gope
Journal:  Ecancermedicalscience       Date:  2012-12-20

Review 6.  Risk Factors of Acoustic Neuroma: Systematic Review and Meta-Analysis.

Authors:  Mantao Chen; Zuoxu Fan; Xiujue Zheng; Fei Cao; Liang Wang
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.